Kezar Life Sciences, Inc.
NASDAQ:KZR
6.64 (USD) • At close December 27, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | -5.428 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0.261 | 0.26 | 0.28 | 0.278 | 0.249 | 0.259 | 13.001 | 0.458 | 0.431 | 0.417 | 0.387 | 0.378 | 0.373 | 0.372 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | -0.261 | -0.26 | -5.708 | 6.722 | -0.249 | -0.259 | -13.001 | -0.458 | -0.431 | -0.417 | -0.387 | -0.378 | -0.373 | -0.372 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 1.052 | 0.96 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 16.242 | 16.298 | 17.172 | 22.642 | 23.738 | 20.999 | 18.318 | 4.859 | 13.86 | 11.346 | 10.944 | 9.781 | 10.527 | 9.341 | 9.286 | 8.117 | 8.259 | 7.148 | 7.457 | 7.431 | 7.08 | 6.925 | 5.927 | 4.673 | 4.664 | 5.228 | 3.572 | 1.636 | 1.557 | 1.445 | 1.831 |
| General & Administrative Expenses
| 5.706 | 5.603 | 6.539 | 5.76 | 8.789 | 5.785 | 6.206 | 5.175 | 5.067 | 4.977 | 4.934 | 4.322 | 3.972 | 3.668 | 3.762 | 2.951 | 3.292 | 2.705 | 3.021 | 2.566 | 2.601 | 2.43 | 2.382 | 1.753 | 1.6 | 1.722 | 1.514 | 0.783 | 0.635 | 0.436 | 0.426 |
| Selling & Marketing Expenses
| 0 | -0.261 | -0.26 | -0.28 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 5.706 | 5.342 | 6.279 | 5.48 | 8.789 | 5.785 | 6.206 | 5.175 | 5.067 | 4.977 | 4.934 | 4.322 | 3.972 | 3.668 | 3.762 | 2.951 | 3.292 | 2.705 | 3.021 | 2.566 | 2.601 | 2.43 | 2.382 | 1.753 | 1.6 | 1.722 | 1.514 | 0.783 | 0.635 | 0.436 | 0.426 |
| Other Expenses
| 0 | 1.482 | 0 | 6.187 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 21.948 | 21.64 | 23.451 | 28.122 | 32.527 | 26.784 | 24.524 | 20.034 | 18.927 | 16.323 | 15.878 | 14.103 | 14.499 | 13.009 | 13.048 | 11.068 | 11.551 | 9.853 | 10.478 | 9.997 | 9.681 | 9.355 | 8.309 | 6.426 | 6.264 | 6.95 | 5.086 | 2.419 | 2.192 | 1.881 | 2.257 |
| Operating Income
| -21.948 | -23.383 | -23.711 | -28.402 | -25.527 | -26.784 | -24.524 | -20.034 | -18.927 | -16.323 | -15.878 | -14.103 | -14.499 | -13.009 | -13.048 | -11.068 | -11.551 | -9.853 | -10.478 | -9.997 | -9.681 | -9.355 | -8.309 | -6.426 | -6.264 | -6.95 | -5.086 | -2.419 | -2.192 | -1.881 | -2.257 |
| Operating Income Ratio
| 0 | 0 | 0 | 5.232 | -3.647 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.635 | 1.836 | 2.053 | -3.858 | 2.424 | 2.476 | 2.325 | 1.853 | 1.08 | 0.136 | -0.146 | -0.109 | 0.037 | 0.047 | 0.054 | 0.127 | 0.262 | 0.353 | 0.466 | 0.418 | 0.533 | 0.637 | 0.667 | 0.644 | 0.601 | 0.175 | 0.139 | 0.119 | 0.112 | 0.001 | 0 |
| Income Before Tax
| -20.313 | -21.547 | -21.658 | -32.26 | -23.103 | -24.308 | -22.199 | -18.181 | -17.847 | -16.187 | -16.024 | -14.212 | -14.462 | -12.962 | -12.994 | -10.941 | -11.289 | -9.5 | -10.012 | -9.579 | -9.148 | -8.718 | -7.642 | -5.782 | -5.663 | -6.775 | -4.947 | -2.3 | -2.08 | -1.88 | -2.257 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 5.943 | -3.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0.217 | -0.628 | -0.278 | 2.861 | -1.955 | -1.853 | -1.08 | 0.408 | 0.146 | -0.337 | -0.108 | 0 | 0 | -0.368 | 0 | -0.369 | 0 | -0.34 | -0.333 | 0 | 0 | -0.204 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -20.313 | -21.547 | -21.658 | -32.26 | -23.103 | -24.308 | -20.244 | -16.328 | -16.767 | -16.187 | -16.17 | -14.212 | -14.462 | -12.962 | -12.994 | -10.941 | -11.289 | -9.5 | -10.012 | -9.579 | -9.148 | -8.718 | -7.642 | -5.782 | -5.663 | -6.775 | -4.947 | -2.3 | -2.08 | -1.88 | -2.257 |
| Net Income Ratio
| 0 | 0 | 0 | 5.943 | -3.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.28 | -2.96 | -0.3 | -0.44 | -0.32 | -0.34 | -0.28 | -0.23 | -0.23 | -0.25 | -0.27 | -0.25 | -0.28 | -0.25 | -0.25 | -0.22 | -0.23 | -0.22 | -0.2 | -0.5 | -0.48 | -0.46 | -0.4 | -0.3 | -0.3 | -3.31 | -0.28 | -0.18 | -0.16 | -0.14 | -0.17 |
| EPS Diluted
| -0.28 | -2.96 | -0.3 | -0.44 | -0.32 | -0.34 | -0.28 | -0.23 | -0.23 | -0.25 | -0.27 | -0.25 | -0.28 | -0.25 | -0.25 | -0.22 | -0.23 | -0.22 | -0.2 | -0.5 | -0.48 | -0.46 | -0.4 | -0.3 | -0.3 | -3.31 | -0.28 | -0.18 | -0.16 | -0.14 | -0.17 |
| EBITDA
| -19.65 | -20.885 | -20.998 | -31.581 | -22.429 | -23.674 | -21.649 | -17.832 | -17.079 | -15.484 | -15.432 | -13.404 | -14.121 | -12.589 | -12.622 | -10.7 | -11.106 | -9.484 | -10.116 | -9.657 | -9.348 | -9.03 | -8.006 | -6.222 | -6.059 | -6.756 | -4.999 | -2.374 | -2.149 | -1.838 | -2.213 |
| EBITDA Ratio
| 0 | 0 | 0 | 5.181 | -3.647 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |